John Ilgenfritz

549 total citations
10 papers, 394 citations indexed

About

John Ilgenfritz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Paleontology. According to data from OpenAlex, John Ilgenfritz has authored 10 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 1 paper in Surgery and 1 paper in Paleontology. Recurrent topics in John Ilgenfritz's work include Cardiac pacing and defibrillation studies (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Heart Failure Treatment and Management (3 papers). John Ilgenfritz is often cited by papers focused on Cardiac pacing and defibrillation studies (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Heart Failure Treatment and Management (3 papers). John Ilgenfritz collaborates with scholars based in United States, Sweden and Canada. John Ilgenfritz's co-authors include Mats Brittberg, David P. Recker, Daniël B.F. Saris, Kate Gelperin, Mel Blumenthal, Leif Erhardt, Jay F. Custer, James Aisenberg, Edward J. Brown and Paul H. Chew and has published in prestigious journals such as European Heart Journal, The American Journal of Sports Medicine and The American Journal of Cardiology.

In The Last Decade

John Ilgenfritz

10 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ilgenfritz United States 8 180 174 154 40 34 10 394
A Mashiah Israel 10 163 0.9× 37 0.2× 38 0.2× 8 0.2× 79 2.3× 30 315
R. Wakefield United Kingdom 7 183 1.0× 587 3.4× 86 0.6× 5 0.1× 5 0.1× 13 631
K. Shariat Germany 8 229 1.3× 36 0.2× 22 0.1× 6 0.1× 8 0.2× 17 440
Francisco Javier García Criado United States 10 129 0.7× 43 0.2× 29 0.2× 27 0.7× 28 0.8× 33 262
Mario Vicente Barrero Spain 10 60 0.3× 24 0.1× 24 0.2× 20 0.5× 19 0.6× 29 340
Harvey Chant United Kingdom 10 118 0.7× 17 0.1× 91 0.6× 4 0.1× 47 1.4× 14 329
Munir Nashashibi Israel 7 98 0.5× 59 0.3× 19 0.1× 6 0.1× 6 0.2× 15 280
Scott C. McGovern United States 5 254 1.4× 11 0.1× 27 0.2× 5 0.1× 42 1.2× 5 362
Robert Kolundžić Croatia 12 211 1.2× 37 0.2× 42 0.3× 34 1.0× 29 314
M.-O. Benoît France 6 158 0.9× 38 0.2× 217 1.4× 12 0.4× 8 385

Countries citing papers authored by John Ilgenfritz

Since Specialization
Citations

This map shows the geographic impact of John Ilgenfritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ilgenfritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ilgenfritz more than expected).

Fields of papers citing papers by John Ilgenfritz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ilgenfritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ilgenfritz. The network helps show where John Ilgenfritz may publish in the future.

Co-authorship network of co-authors of John Ilgenfritz

This figure shows the co-authorship network connecting the top 25 collaborators of John Ilgenfritz. A scholar is included among the top collaborators of John Ilgenfritz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ilgenfritz. John Ilgenfritz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kolb, Jennifer M., Jay Desai, Lars Wallentin, et al.. (2018). Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran. Digestive Diseases and Sciences. 63(7). 1878–1889. 15 indexed citations
2.
Brittberg, Mats, et al.. (2018). Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial. The American Journal of Sports Medicine. 46(6). 1343–1351. 193 indexed citations
3.
Desai, Jay, Jennifer M. Kolb, Lars Wallentin, et al.. (2016). Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation. Clinical Gastroenterology and Hepatology. 15(5). 682–690. 41 indexed citations
4.
Chaudhuri, Ajay, Julio Rosenstock, Andrés Digenio, et al.. (2011). Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient‐level pooled analysis. Diabetes/Metabolism Research and Reviews. 28(3). 258–267. 14 indexed citations
5.
Anderson, David E., et al.. (2004). Safety of AT-1015, a novel 5-HT2A antagonist, in combination with high-dose aspirin: an open-label study. International Journal of Clinical Pharmacology and Therapeutics. 42(2). 98–102. 1 indexed citations
6.
Sharma, Satish, et al.. (1999). The Hemodynamic Effects of Long-Term ACE Inhibition with Fosinopril in Patients with Heart Failure. American Journal of Therapeutics. 6(4). 181–190. 4 indexed citations
7.
Gottlieb, Stephen S., et al.. (1996). Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure. The American Journal of Cardiology. 78(12). 1411–1415. 12 indexed citations
8.
Brown, Edward J., et al.. (1995). Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. The American Journal of Cardiology. 75(8). 596–600. 32 indexed citations
9.
Erhardt, Leif, et al.. (1995). Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. European Heart Journal. 16(12). 1892–1899. 63 indexed citations
10.
Custer, Jay F., et al.. (1988). A cautionary note on the use of chemstrips for detection of blood residues on prehistoric stone tools. Journal of Archaeological Science. 15(3). 343–345. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Mashiah Breakdown of academic impact, for papers by R. Wakefield Breakdown of academic impact, for papers by K. Shariat Breakdown of academic impact, for papers by Francisco Javier García Criado Breakdown of academic impact, for papers by Mario Vicente Barrero Breakdown of academic impact, for papers by Harvey Chant Breakdown of academic impact, for papers by Munir Nashashibi Breakdown of academic impact, for papers by Scott C. McGovern Breakdown of academic impact, for papers by Robert Kolundžić Breakdown of academic impact, for papers by M.-O. Benoît
Rankless by CCL
2026